Patent EP0398710A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US5198537A Expired / Lapsed US ⏱️ 0.0 years remaining

Digoxigenin derivatives and use thereof

Assignee: Roche Diagnostics GmbH
•
Filing: 1989-10-25
•
Granted: 1993-03-30
•
Expires: 2009-10-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides digoxigenin derivatives of the formula: ##STR1## wherein n is a whole number of from 1 to 4 and Z is a carboxyl group or a functional derivative derived therefrom. The present invention also provides digoxigenin conjugates of the general formula: ##STR2## wherein the carrier is an immunogenic carrier material, a nucleic acid or a labelled immunocomponent of a labelled digoxigenin immunoconjugate for use in an immunoassay, m is a number from 1 to the number of coupling positions available on the carrier and Y is the group formed by the reaction of the carboxyl function Z of the digoxigenin derivative of general formula (I) with the reacting position of the carrier material. Also described are uses of these conjugates as nucleic acid probes, immunogens, and in immunoassay.

Inventors

  • 👤 Erasmus Huber
  • 👤 Klaus Muhlegger
  • 👤 Herbert von der Eltz
  • 👤 Bruno Zink

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 07:56
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; C; C07; C07J; C07J19/00; C07J41/00; C07J41/0033; C07J41/0055; C07J43/00; C07J43/003; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 25 words
Digoxigenin derivative of formula: ##STR9## wherein n is a whole number from 1 to 4, and Z is --CN, --COOC 2 H 5 , ##STR10##
Claim 2
Dependent Claim 25 words
Digoxigenin derivative of formula: ##STR9## wherein n is a whole number from 1 to 4, and Z is --CN, --COOC 2 H 5 , ##STR10##
Claim 3
Dependent Claim 9 words
Digoxigenin derivative of claim 1, wherein n is 1.
Claim 4
Dependent Claim 48 words
Digoxigenin conjugate of the formula: ##STR11## wherein said carrier is an immunogenic protein or polypeptide, a nucleic acid or a labelled immunocomponent of a labelled digoxigenin immunoconjugate, m is a whole number from 1 to the number of coupling positions available on said carrier, and Y is ##STR12##
Claim 5
Dependent Claim 48 words
Digoxigenin conjugate of the formula: ##STR11## wherein said carrier is an immunogenic protein or polypeptide, a nucleic acid or a labelled immunocomponent of a labelled digoxigenin immunoconjugate, m is a whole number from 1 to the number of coupling positions available on said carrier, and Y is ##STR12##
Claim 6
Dependent Claim 14 words
Digoxigenin conjugate of claim 3, wherein said carrier is an immunogenic protein or polypeptide.
Claim 7
Dependent Claim 12 words
Digoxigenin conjugate of claim 3, wherein said carrier is a nucleic acid.
Claim 8
Dependent Claim 12 words
Digoxigenin conjugate of claim 3, wherein said carrier is a labelled immunocomponent.

References Cited (Backward Citations)

US3855208A Cited
US3925355A Cited
US4064227A Cited
US4082747A Cited
CH604164A5 Cited
GB2003480A Cited
US4469797A Cited
EP0174753A1 Cited
EP0173251A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-03-29 1996-09-28 1997-03-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-03-29 2000-09-28 2001-03-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-03-29 2004-09-28 2005-03-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag